Hyaluronic Acid Products Market Size & Growth Analysis to 2030

The global hyaluronic acid products market size was accounted for over USD 9 billion in 2019 and projected to grow at the CAGR of 7.6% market during the forecast period 2020-2027. Hyaluronic acid is useful for value addition to permeability and cell proliferation and considered as a vital component of the extracellular matrix. Hyaluronic acid products have diverse applications such as dermatology orthopedic surgery, ophthalmology, rheumatology, otolaryngology, and plastic surgery, wound healing and drug delivery. Hyaluronic acid is also available in various dosage forms as per its applications; e.g. in osteoarthritis treatment, HA injections are administered in the synovial cavity. The market for hyaluronic acid products is anticipated to experience tremendous growth mainly due to factors such as aging population, increasing patient awareness and increasing demand for minimally-invasive procedures.

Market Insights:

Rising prevalence of osteoarthritis and increasing demand for cosmetic surgeries that require the use of hyaluronic acid are the key growth factors in the hyaluronic acid products market. In base year 2019, the five injection regimen held the largest share in the global hyaluronic acid products market because of high drug safety and efficacy. Hyaluronic acid products market is further segmented in terms of application areas such as osteoarthritis, ophthalmic, dermal fillers and vesicoureteral reflux applications. In 2019, osteoarthritis held largest market share and it is anticipated to grow further during the forecast period due to increasing number of patients suffering from osteoarthritis, high public awareness and early disease diagnosis and remedial surgeries. The hyaluronic acid products market is currently dominated by North America due to increasing prevalence of osteoarthritis, increasing demand for cosmetic surgery and supportive reimbursement scenario. On the other hand, Asia Pacific is anticipated to be the fastest growing market for hyaluronic acid product market due to aging population base, rising public awareness and rapidly developing healthcare infrastructure.

Market Segment Insights:

The hyaluronic acid products market is majorly segmented into types such as single injections, three-cycle injections and five-cycle injections. The five injection regimen held the largest share in the global hyaluronic acid products market. However, the single injection regimen is expected to grow at a faster rate as compared to the other alternatives due to the shifting patient preferences towards the shorter treatment period owing to low risk of side effects. The application segment consists of (vesicoureteral reflux, dermal fillers, ophthalmic and osteoarthritis). Osteoarthritis held the largest revenue share in the application segment due to factors such as increasing patient pool suffering with osteoarthritis and aging population.

Global Hyaluronic Acid Product Market Segmentation:

By Product, 2018–2027 ($ Million)

• Single Injection
• Three Injection Cycle
• Five Injections Cycle

By Application, 2018–2027 ($ Million)

• Osteoarthritis
• Ophthalmic
• Dermal Fillers
• Vesicoureteral

By Geography, 2018-2027 ($ Million)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Regional Insights:

North America, Latin America, Europe, Middle East and Africa and Asia Pacific, markets together form the major regional markets for hyaluronic acid products. These regional markets are further sub-segmented into country specific markets on the basis of demand and market growth of hyaluronic acid products. Among the considered regional markets, North America currently dominates the global hyaluronic acid products market, with United Sates being the largest county-level market. Increase in number of patients suffering from osteoarthritis disease, rising demand for cosmetic surgery, increasing demand for minimally invasive procedures and supportive reimbursement policies.  On the other hand, Asia Pacific is anticipated to be the fastest growing market for hyaluronic acid products due to aging population base, rising public awareness and developed healthcare infrastructure.

Market Competition Assessment:

Key players in the global hyaluronic acid product market are Anika Therapeutics, Inc., Allergan, Inc., AstraZeneca, Sanofi S.A., Ferring B.V., Seikagaku Corporation, Salix Pharmaceutical, Fidia Farmaceutici, Zimmer Biomet and others.

List of Key Companies:

• Anika Therapeutics, Ltd.
• Allergan plc
• AstaZeneca
• Ferring B.V.
• Fidia Farmaceutici
• Salix Pharmaceutical, Inc.
• Sanofi S.A.
• Seikagaku Corporation
• Zimmer Biomet

Key Questions Answered by Hyaluronic Acid Products Market Report

• Global hyaluronic acid products market forecasts from 2020-2027
• Regional hyaluronic acid products market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
• Country level forecasts from 2020-2027 covering 15 major countries from aforementioned regions
• Hyaluronic Acid Products submarket forecasts from 2020-2027 covering the market by product, by application, and geography
• Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to hyaluronic acid products market
• Analysis of the key factors driving and restraining the growth of the global, regional and country level hyaluronic acid products markets from 2020-2027
• Competitive Landscape and market positioning of top 10 players operating in the hyaluronic acid products market

Request a full report sample in PDF format @ https://www.researchcorridor.com/request-sample/?id=13322